GE Healthcare recalls 688 medical systems, FDA says ‘most serious’
GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe.
Drugs
Medical
Pharma
Drugs
Pharma
FDA puts on hold Blueprint Medicines’ clinical trial for solid cancers
The USFDA has put on hold Blueprint Medicines Corporation's clinical trial of BLU-222 due to visual adverse events seen in some patients, according.
Drugs
Health
Pharma
FDA recommends new rules for cannabidiol products
The FDA has suggested new regulations for the use of cannabidiol products, as the existing rules on food and supplements were insufficient for.
Drugs
Pharma
US regulatory nod for Lupin’s HIV drug in the works
Pharma major Lupin has received a ‘tentative approval’, from the United States Food and Drug Administration (FDA), to market medicines used to treat.
Drugs
Pharma
USFDA grants ‘tentative approval’ to Zydus’ mental health drug
The USFDA has granted Zydus Lifesciences Limited ‘tentative approval’ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Drugs
Medical
Pharma
Alembic gets USFDA nod for Fulvestrant to treat breast cancer
Alembic Pharma receives USFDA approval for breast cancer drug--Fulvestrant injection
Drugs
Pharma
Pfizer, BioNTech start trial on one vaccine to prevent both Covid-19, influenza
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
Health
Pharma
Dearth of Philips MRI-guided breast biopsy plates hit US
The FDA has told healthcare providers to consider different MRI-guided breast biopsy procedure options due to a shortage of grid plates and coil.
Drugs
Pharma
Alembic gets USFDA nod for oncology injection Paclitaxel
Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in.
Medical
USFDA approves Zydus Lifesciences anti-fungal injection
USFDA approves Zydus Lifesciences anti-fungal injection HQ Team October 26, 2022: Zydus Lifesciences announced that it had received final approval from the USFDA.